References
- Watson WA, Litovitz TL, Rodgers GC, Klein-Schwartz K, Reid N, Youniss J, Flanagan A, Wruk KM. 2004 annual association of Poison Control Centers Toxic Expsoure Surveillance System. Amer J Emerg Med 2005; 23: 589–666
- Lai MW, Klein-Schwartz K, Rodgers GC, Abrams JY, Haber DA, Bronstein AC, Wruk KM. 2005 annual report of the American Association of Poison Control Centers’ National Poisoning and Expsoure Database. Clin Toxicol 2006; 44: 803–932
- Klein-Schwartz W, Gorman R, Oderda GM, Baig A. Central nervous system depression from ingestion of nonprescription eyedrops. Amer J Emerg Med 1984; 2: 217–218
- Tobias JD. Central nervous system depression following accidental ingestion of Visine eye drops. Clin Pediatr 1996; 35(10)539–40
- Jensen P, Edgren B, Hall L, Ring JC. Hemodynamic effects following ingestion of an imidazoline-containing product. Pediatr Emerg Med 1989; 5: 110–112
- Daggy A, Kaplan R, Roberge R, Akhtar J. Pediatric Visine (tetrahydrozoline) ingestion: Case report and review of imidazoline toxicity. Vet Human Toxicol 2003; 45: 210–212
- Claudet I, Fries F. Danger of nasal vasoconstrictors in infants. Apropos of a case. Arch Pediatr 1997; 4(6)538–41
- Mahieu LM, Rooman RP, Goossens E. Imidazoline intoxication in children. Eur J Pediatr 1993; 152(11)944–6
- Osterhouldt KC, Henretig FM. Sinoatrial node arrest following tetrahydrozoline ingestion. J Emerg Med 2004; 27: 313–314
- Lev R, Clark RF. Visine overdose: Case report of an adult with hemodynamic compromise. J Emerg Med 1995; 13: 649–652
- Spiller HA, Rogers J, Sawyer TS. Drug facilitated sexual assault using an over-the-counter ocular solution containing tetrahydrozoline (Visine). Legal Med 2007; 9: 192–195
- Higgins GL, 3rd, Campbell B, Wallace K, Talbot S. Pediatric poisoning from over-the-counter imidazoline-containing products. Ann Emerg Med 1991; 20: 655–8